-
公开(公告)号:US07951836B2
公开(公告)日:2011-05-31
申请号:US11818676
申请日:2007-06-15
IPC分类号: A61K31/5355 , C07D413/08
CPC分类号: C07D207/06 , C07D207/08 , C07D211/16 , C07D403/10 , C07D407/10
摘要: The present invention relates to compounds of formula I wherein R1, R2, R3, X, n, and m are as defined herein and to pharmaceutically acceptable acid addition salts thereof, to pharmaceutical compositions containing them, and to methods for treating neurological and neuropsychiatric disorders.
摘要翻译: 本发明涉及式I化合物,其中R 1,R 2,R 3,X,n和m如本文所定义,及其药学上可接受的酸加成盐,含有它们的药物组合物,以及治疗神经和神经精神障碍 。
-
公开(公告)号:US20080076806A1
公开(公告)日:2008-03-27
申请号:US11893932
申请日:2007-08-17
IPC分类号: A61K31/164 , A61K31/381 , A61K31/4409 , C07C233/31 , C07D211/04 , C07D333/22
CPC分类号: C07C237/22 , C07C255/57 , C07C271/22 , C07C275/24 , C07C2601/14 , C07D213/40 , C07D213/81 , C07D261/18 , C07D275/02 , C07D279/02 , C07D307/79 , C07D333/20 , C07D333/38 , C07D333/44 , C07D335/18
摘要: The present invention relates to compounds of formula I wherein R1, R2, R3, R4, R5, X, and n are as defined herein and the dotted line denotes an optional bond and pharmaceutically acceptable acid addition salts thereof. The compounds are useful in the treatment of neurological and neuropsychiatric disorders.
摘要翻译: 本发明涉及式Ⅰ化合物,其中R 1,R 2,R 3,R 4, R 5,X和n如本文所定义,虚线表示任选的键及其药学上可接受的酸加成盐。 该化合物可用于治疗神经和神经精神障碍。
-
公开(公告)号:US20080058331A1
公开(公告)日:2008-03-06
申请号:US11895097
申请日:2007-08-23
IPC分类号: A61K31/5375 , A61K31/164 , A61K31/341 , A61K31/357 , A61P25/00 , C07C233/00 , C07D261/06 , C07D307/02 , C07D333/02 , C07D333/50 , C07D317/44 , C07D295/00 , C07D213/02 , A61P25/18 , A61K31/381 , A61K31/42 , A61K31/44
CPC分类号: C07C237/12 , C07C255/57 , C07D213/81 , C07D213/82 , C07D317/52 , C07D333/20 , C07D333/70
摘要: The present invention relates to compounds of formula I wherein R1, R2, R3, R4, and X are as defined herein or to pharmaceutically acceptable acid addition salts thereof, with the exception of 4-methoxy-N-[2-oxo-2-(phenylamino)ethyl]-N-phenyl-benzamide, 4-chloro-N-[2-[(4-methylphenyl)amino]-2-oxoethyl]-N-phenyl-benzamide, 4-chloro-N-[2-[5-chloro-2-methoxyphenyl)amino]-2-oxoethyl]-N-benzamide, 4-methyl-N-[2-oxo-2-[(2,4,6-trichlorophenyl)amino]ethyl]-N-benzamide, N-[2-[(4-methylphenyl)amino]-2-oxoethyl]-N-phenyl-benzamide, 4-methyl-N-[2-[(4-methylphenyl)amino]-2-oxoethyl]-N-phenyl-benzamide, 4-chloro-N-(2-oxo-2-[(2,4,6-trichlorophenyl)amino]ethyl]-N-benzamide and N-[2-[(2,4-dimethoxyphenyl)amino]-2-oxoethyl]-N-[(2-fluorophenyl)methyl]-benzeneacetamide. The compounds are useful in the treatment of neurological and neuropsychiatric disorders.
摘要翻译: 本发明涉及式Ⅰ化合物,其中R 1,R 2,R 3,R 4, 和X如本文所定义,或其药学上可接受的酸加成盐,除了4-甲氧基-N- [2-氧代-2-(苯基氨基)乙基] -N-苯基 - 苯甲酰胺,4-氯-N- [2 - [(4-甲基苯基)氨基] -2-氧代乙基] -N-苯基 - 苯甲酰胺,4-氯-N- [2- [5-氯-2-甲氧基苯基)氨基] -2-氧代乙基] -N - 苯甲酰胺,4-甲基-N- [2-氧代-2 - [(2,4,6-三氯苯基)氨基]乙基] -N-苯甲酰胺,N- [2 - [(4-甲基苯基)氨基] -2 - 氧代乙基] -N-苯基 - 苯甲酰胺,4-甲基-N- [2 - [(4-甲基苯基)氨基] -2-氧代乙基] -N-苯基 - 苯甲酰胺,4-氯-N-(2-氧代 - 2 - [(2,4,6-三氯苯基)氨基]乙基] -N-苯甲酰胺和N- [2 - [(2,4-二甲氧基苯基)氨基] -2-氧代乙基] -N - [(2-氟苯基) 甲基] - 苯乙酰胺。这些化合物可用于治疗神经和神经精神障碍。
-
公开(公告)号:US20070299071A1
公开(公告)日:2007-12-27
申请号:US11818676
申请日:2007-06-15
IPC分类号: A61K31/164 , A61K31/4025 , A61K31/5355 , C07C233/64 , C07D207/04 , C07D413/08
CPC分类号: C07D207/06 , C07D207/08 , C07D211/16 , C07D403/10 , C07D407/10
摘要: The present invention relates to compounds of formula I wherein R1, R2, R3, X, n, and m are as defined herein and to pharmaceutically acceptable acid addition salts thereof, to pharmaceutical compositions containing them, and to methods for treating neurological and neuropsychiatric disorders.
摘要翻译: 本发明涉及式I化合物,其中R 1,R 2,R 3,X,n和m如本文所定义 及其药学上可接受的酸加成盐,含有它们的药物组合物,以及治疗神经和神经精神障碍的方法。
-
公开(公告)号:US20060178381A1
公开(公告)日:2006-08-10
申请号:US11343365
申请日:2006-01-31
IPC分类号: A61K31/519 , A61K31/4745 , A61K31/4184 , A61K31/416 , A61K31/4035 , A61K31/405 , C07D471/02 , C07D487/02
CPC分类号: C07D471/04 , C07D209/08 , C07D209/44 , C07D209/46 , C07D209/88 , C07D231/56 , C07D235/06 , C07D401/04 , C07D403/04 , C07D405/04 , C07D405/12 , C07D409/04 , C07D413/04 , C07D417/04 , C07D487/04 , C07D491/08
摘要: The present invention relates to compounds of formula I wherein R1, R2, and are defined in the specification and to pharmaceutically acceptable acid addition salts thereof.
摘要翻译: 本发明涉及其中R 1,R 2,和在本说明书中定义的式I化合物及其药学上可接受的酸加成盐。
-
公开(公告)号:US20060160788A1
公开(公告)日:2006-07-20
申请号:US11332999
申请日:2006-01-17
IPC分类号: A61K31/445 , A61K31/4015 , A61K31/397 , C07D211/44 , C07D207/02 , C07D205/02
CPC分类号: C07D207/12 , C07D205/04 , C07D211/46 , C07D401/12
摘要: The present invention relates to compounds of formula I wherein R1, R2, R3, n, and m, are as defined in the specification and to pharmaceutically acceptable acid addition salts thereof. These compounds are good inhibitors of the glycine transporter 1 (GlyT-1) and are useful for the treatment of CNS disorders such as schizophrenia, cognitive impairment, and Alzheimer's disease.
摘要翻译: 本发明涉及其中R 1,R 2,R 3,n和m的式I化合物如 规格及其药学上可接受的酸加成盐。 这些化合物是甘氨酸转运蛋白1(GlyT-1)的良好抑制剂,可用于治疗中枢神经系统疾病如精神分裂症,认知障碍和阿尔茨海默病。
-
公开(公告)号:US20060148797A1
公开(公告)日:2006-07-06
申请号:US11302403
申请日:2005-12-13
IPC分类号: A61K31/5377 , C07D413/02
CPC分类号: C07D211/70
摘要: The present invention relates to compounds of formula I wherein R1, R2, and Ar; are as defined in the specification. The invention also provides pharmaceutically acceptable acid addition salts thereof and methods for the treatment of neurological and neuropsychiatric disorders, such as schizophrenia, cognitive impairment, and Alzheimer's disease.
摘要翻译: 本发明涉及式I化合物,其中R 1,R 2,R 2和Ar; 如说明书中所定义。 本发明还提供其药学上可接受的酸加成盐以及用于治疗神经和神经精神疾病如精神分裂症,认知障碍和阿尔茨海默病的方法。
-
公开(公告)号:US20060128713A1
公开(公告)日:2006-06-15
申请号:US11297597
申请日:2005-12-08
IPC分类号: A61K31/498 , A61K31/4745 , A61K31/4743 , C07D498/02 , C07D487/04
CPC分类号: C07D471/04 , C07D487/04 , C07D495/04 , C07D513/04
摘要: The present invention relates to compounds of the general formula I and R1, R′,; R″, R2, R3, R4, R5, R6, R7, m and n are as defined in the specification, and to pharmaceutically active acid addition salts thereof. The compounds of the invention are useful in the treatment of neurological and neuropsychiatric disorders.
摘要翻译: 本发明涉及通式I和R 1,R'的化合物; R“,R”2,R 3,R 4,R 5,R 6, R 7,R 7,m和n如说明书中所定义,及其药学活性的酸加成盐。 本发明的化合物可用于治疗神经和神经精神障碍。
-
公开(公告)号:US07265126B2
公开(公告)日:2007-09-04
申请号:US11028125
申请日:2005-01-03
IPC分类号: A61K31/438 , C07D471/10
CPC分类号: C07D471/10
摘要: The present invention relates to compounds of formula wherein A-B, R1, R2, R3, R4, and n are as defined herein; and to pharmaceutically acceptable salts thereof. The compounds of formula I may be used in the treatment of neurological and neuropsychiatric disorders.
摘要翻译: 本发明涉及下式的化合物,其中AB,R 1,R 2,R 3,R 4, ,和n如本文所定义; 和其药学上可接受的盐。 式I化合物可用于治疗神经和神经精神障碍。
-
公开(公告)号:US20050154000A1
公开(公告)日:2005-07-14
申请号:US11028125
申请日:2005-01-03
申请人: Synese Jolidon , Emmanuel Pinard , Andrew Thomas
发明人: Synese Jolidon , Emmanuel Pinard , Andrew Thomas
IPC分类号: A61K31/435 , C07D471/10 , A61K31/4747
CPC分类号: C07D471/10
摘要: The present invention relates to compounds of formula wherein A—B, R1, R2, R3, R4, and n are as defined herein; and to pharmaceutically acceptable salts thereof. The compounds of formula I may be used in the treatment of neurological and neuropsychiatric disorders.
摘要翻译: 本发明涉及下式的化合物,其中AB,R 1,R 2,R 3,R 4, ,和n如本文所定义; 和其药学上可接受的盐。 式I化合物可用于治疗神经和神经精神障碍。
-
-
-
-
-
-
-
-
-